Should COHR Stock Be in Your Portfolio Before Q4 Earnings?

                                                                  Image Source: Zacks Investment Research

The company has a strong history of earnings surprises. Earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and matched once, with an average earnings surprise of 6.2%.

COHR’s Higher Chance of Q3 Earnings Beat

Our model predicts a likely earnings beat for COHR this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.

COHR has an Earnings ESP of +2.65% and a Zacks Rank #3.

You can see the complete list of today’s Zacks #1 Rank stocks here.

Coherent’s Q4 Growth Hinges on AI Demand, Capacity Expansion and Margin Gains

Fiscal fourth-quarter revenues are likely to have benefited from exceptional demand in Datacenter & Communications, led by 800G and rapidly ramping 1.6T transceivers, OCS systems and initial scale-out CPO revenues. Capacity expansion is another key catalyst, with Coherent accelerating the doubling of internal indium phosphide output and ramping 6-inch production. Improving industrial demand could provide additional support. On the bottom line, higher volumes, a richer 1.6T mix and 6-inch manufacturing efficiencies should aid gross margins. However, sequentially higher capital investment and operating expenses may temper profitability gains.

COHR Stock Experiencing Growth

Coherent shares have gained a massive 195% over the past year and 12% in the past month. This performance clearly indicates consistent growth in the stock.

Based on forward 12-month Price/Earnings, COHR is currently trading at 42.32X, way above the industry’s 21.7X. If we look at the forward 12-month Price/Sales ratio, the company’s shares are currently trading at 7.27X forward sales, well above the industry’s 2.8X.

                                                                      Image Source: Zacks Investment Research

Coherent is a Hold Ahead of Q4 Earnings

Coherent’s strong demand backdrop, expanding AI-driven Datacenter & Communications business, and accelerating capacity investments support its long-term growth prospects. Improving product mix and manufacturing efficiencies could also aid profitability as production ramps. However, the stock’s sharp appreciation and premium valuation suggest that much of the optimism surrounding these growth drivers may already be reflected in the share price. With expectations elevated heading into the fiscal fourth-quarter report, any disappointment in execution, margins or the pace of capacity conversion could pressure the stock. Investors may therefore prefer to maintain existing positions and await greater clarity after earnings, making COHR a Hold.

Peer View

Among U.S.-listed peers, Lumentum Holdings LITE and IPG Photonics IPGP offer useful comparisons for investors evaluating Coherent. Like Coherent, both LITE and IPGP operate in optical components and photonics markets that benefit from increasing demand for high-speed data communications and advanced laser technologies. However, Coherent currently stands apart because of its unusually strong AI infrastructure exposure, record backlog extending into 2028, long-term supply agreements through 2030, and a significantly strengthened balance sheet following NVIDIA's strategic investment. These factors have helped improve earnings visibility and differentiate Coherent's growth profile within the photonics industry.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research